**Question:** Antidote of Heparin is:

A. Protamine Sulfate
B. Vitamin K
C. Fresh Frozen Plasma
D. Warfarin

**Core Concept:** Heparin is a anticoagulant drug used to prevent blood clots, reduce blood viscosity, and enhance blood flow in patients at risk of thrombosis. It works by inhibiting the enzyme Factor Xa, which prevents the formation of thrombin and ultimately prevents clot formation.

**Why the Correct Answer is Right:** Protamine Sulfate is the specific antidote for Heparin. It reverses the anticoagulant effect of Heparin by neutralizing its action on Factor Xa, thereby restoring the clotting cascade and preventing excessive bleeding.

**Why Each Wrong Option is Incorrect:**

**Option B (Vitamin K):** Vitamin K is essential for the synthesis of clotting factors II, VII, IX, X, protein C, and protein S. Vitamin K deficiency results in bleeding diathesis. However, Vitamin K supplementation would not reverse the anticoagulant effect of Heparin as it functions in a different pathway.

**Option C (Fresh Frozen Plasma):** Fresh Frozen Plasma (FFP) contains clotting factors and can replace deficient clotting factors in patients with bleeding diathesis. However, FFP is not specific to Heparin and would not neutralize the anticoagulant effect of Heparin without addressing the underlying issue of Heparin exposure.

**Option D (Warfarin):** Warfarin is a vitamin K antagonist and is used to prevent blood clots, similar to Heparin. However, unlike Heparin, Warfarin reverses clotting factor synthesis by inhibiting Vitamin K-dependent clotting factors.

**Core Concept:** Heparin is a glycoprotein commonly used in clinical settings to prevent thrombosis and reduce blood viscosity. Its use is crucial in patients at risk of arterial and venous thrombosis.

**Why the Correct Answer is Right:** Protamine Sulfate is the specific antidote for Heparin as it neutralizes the anticoagulant effect of Heparin by binding to heparin molecules and restoring the clotting cascade, ensuring that patients do not experience excessive bleeding due to Heparin-induced anticoagulation.

**Why Each Wrong Option is Incorrect:**

**Option B (Vitamin K):** Vitamin K antagonists, like warfarin, work by inhibiting the synthesis of Vitamin K-dependent clotting factors. They do not address the anticoagulant effect of Heparin.

**Option C (Fresh Frozen Plasma):** Fresh Frozen Plasma (FFP) improves clotting factors in patients with bleeding diathesis. However, it does not specifically reverse the anticoagulant effect of Heparin and would not be effective in patients receiving Heparin therapy.

**Option D (Warfarin):** Warfarin is a Vitamin K antagonist that inhibits the synthesis of Vitamin K-dependent clotting factors. Unlike Heparin